|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07H 21/00 | (2006.01) |
| C12N 15/11 | (2006.01) |
| (11) | Number of the document | 1943264 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06804123.5 |
| Date of filing the European patent application | 2006-09-25 | |
| (97) | Date of publication of the European application | 2008-07-16 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-29 |
| (46) | Date of publication of the claims translation | 2015-11-25 |
| (86) | Number | PCT/US2006/037313 |
| Date | 2006-09-25 |
| (87) | Number | WO 2007/041071 |
| Date | 2007-04-12 |
| (30) | Number | Date | Country code |
| 241799 | 2005-09-29 | US |
| (72) |
PHIASIVONGSA, Pasit, US
REDKAR, Sanjeev, US
|
| (73) |
Astex Pharmaceuticals, Inc.,
4420 Rosewood Drive, Suite 200, Pleasanton, CA 94588,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Oligonukleotidų analogai, turintys 5-aza-citoziną |
| OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN |
| Payment date | Validity (years) | Amount | |
| 2021-08-31 | 16 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-09-25 |